Glaxo to Curb Drugstore Staples in Russia as It Walks Ethical Tightrope

  • 📰 WSJhealth
  • ⏱ Reading Time:
  • 8 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 53%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

GlaxoSmithKline said it will cut nearly a third of its consumer healthcare products in Russia as the industry grapples with its response to the war in Ukraine

The consequences of harsh economic sanctions against Russia are already being felt across the globe. WSJ’s Greg Ip joins other experts to explain the significance of what has happened so far and how the conflict might transform the global economy.

, drugmakers have mostly maintained sales in the country, saying they are duty-bound to supply sometimes vital medicines even as they condemn the war.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

allinka_z Дорожную этим господам два раза! Они не поймут, переведу: 'Ехай на куй!'

Maybe Russia should take payment for oil in pharmaceutical products, you know, cause they care so much about their citizens.

Oh good, give the Russian people more legitimate reasons to hate the West and support Putin. Great idea!

why only a third? cut them all. squeeze russia as much as possible.

😭

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 413. in HEALTH

Health Health Latest News, Health Health Headlines